quinazolines has been researched along with nitroglycerin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Beaucher, WN | 1 |
| Coffman, JD | 1 |
| Halawa, B | 1 |
| Brandt, D; Goebel, R; Harpf, H; Klein, W | 1 |
| Cohen, ML; Slater, IH; Wiley, KS | 1 |
| Miyamoto, Y; Nakasone, J; Noguchi, K; Sakanashi, M | 1 |
| Ruskoaho, H | 1 |
| Coma-Canella, I; Lopez-Sendon, J | 1 |
| Mukharliamov, NM | 1 |
| Goebel, R; Klein, W | 1 |
| Khomenko, VL; Pomerantsev, VP; Vasiuk, IuA | 1 |
| Cohn, JN | 1 |
| Hirose, R; Ichimura, M; Irie, J; Nomoto, Y; Ohno, T; Okumura, H; Onoda, Y; Takai, H; Yoshimatsu, A | 1 |
| Carvalho, LC; de Moura, RS; Madeira, SV; Miranda, DZ; Pinto, AC; Rangel, BM; Resende, AC; Rubenich, LM; Sicca, RF; Souza, MA; Tano, T | 1 |
| Bennett, BM; Dunkerley, HA; Gillespie, TD; MacPherson, JD; Maurice, DH | 1 |
| Jensen, LT; Olesen, J; Petersen, KA; Tfelt-Hansen, P; Tvedskov, JF | 1 |
| Bhatt, DK; Gupta, S; Hay-Schmidt, A; Jansen-Olesen, I; Olesen, J; Ploug, KB; Ramachandran, R | 1 |
| Chen, J; Li, C; Li, Z; Lin, J; Lu, H; Wu, Z; Yang, X; Zhang, X; Zhang, Y | 1 |
| Christensen, SL; Ernstsen, C; Kristensen, DM; Olesen, J | 1 |
| Li, WQ; Li, YJ; Ma, WJ; Yin, YC; Zhang, BK | 1 |
| Fukushima, K; Gatate, Y; Muramatsu, T; Naganuma, K; Nakano, S; Ohta, A; Shimizu, Y; Sujino, Y; Tanaka, R; Todo, M; Watanabe, A | 1 |
4 review(s) available for quinazolines and nitroglycerin
| Article | Year |
|---|---|
[Use of vasodilator agents in circulatory insufficienty].
Topics: Blood Circulation; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1979 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
Calcitonin gene‑related peptide‑mediated pharmacological effects in cardiovascular and gastrointestinal diseases (Review).
Topics: Calcitonin Gene-Related Peptide; Cardiovascular Diseases; Gastrointestinal Diseases; Gene Expression Regulation; Humans; Indole Alkaloids; Molecular Targeted Therapy; Nitroglycerin; Quinazolines; Up-Regulation | 2021 |
2 trial(s) available for quinazolines and nitroglycerin
| Article | Year |
|---|---|
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine.
Topics: Adult; Calcitonin Gene-Related Peptide Receptor Antagonists; Cross-Over Studies; Dipeptides; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nitroglycerin; Piperazines; Quinazolines; Vasodilator Agents | 2010 |
16 other study(ies) available for quinazolines and nitroglycerin
| Article | Year |
|---|---|
Vasodilator drugs for peripheral vascular disease.
Topics: Humans; Nitroglycerin; Ointments; Prazosin; Quinazolines; Raynaud Disease | 1979 |
Vasodilator drugs for peripheral vascular disease.
Topics: Griseofulvin; Humans; Nitroglycerin; Prazosin; Quinazolines; Raynaud Disease | 1979 |
[Progress in the therapy of acute and chronic cardiac insufficiency by means of systemic vasodilators. Studies with prazosin and nitroglycerin].
Topics: Blood Pressure; Catecholamines; Heart Failure; Heart Ventricles; Humans; Nitroglycerin; Prazosin; Quinazolines | 1979 |
In vitro relaxation of arteries and veins by prazosin: alpha-adrenergic blockade with no direct vasodilation.
Topics: Animals; Arteries; Electric Stimulation; Male; Muscle Tonus; Muscle, Smooth; Nitroglycerin; Norepinephrine; Phentolamine; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Serotonin; Vasodilation; Veins | 1979 |
Pharmacological properties of 5-[(6,7,8-trimethoxy-4-quinazolinyl) amino]-1-pentanyl nitrate maleate in cardiovascular system.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cardiovascular Agents; Cardiovascular System; Coronary Vessels; Dogs; Endothelium, Vascular; Female; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitro Compounds; Nitroglycerin; Norepinephrine; Phenylephrine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance | 1991 |
Prevention of cardiac hypertrophy by long-term treatment with isosorbide dinitrate and prazosin but not by minoxidil in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cardiomegaly; Female; Hypertension; Isosorbide Dinitrate; Male; Minoxidil; Muscle Relaxation; Nitroglycerin; Prazosin; Pyrimidines; Quinazolines; Rats; Rats, Inbred Strains | 1984 |
Haemodynamic effects of nifedipine, nitroglycerine and prazosin in pulmonary hypertension following ingestion of toxic oil.
Topics: Adolescent; Adult; Child; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Nitroglycerin; Oils; Oxygen; Partial Pressure; Prazosin; Quinazolines | 1983 |
[Effect on the peripheral circulation during treatment of cardiac insufficiency].
Topics: Blood Circulation; Cardiac Output; Heart; Heart Diseases; Hemodynamics; Humans; Nitrates; Nitroglycerin; Nitroprusside; Oxygen Consumption; Phentolamine; Piperazines; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1980 |
[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Coronary Disease; Dopamine; Epinephrine; Heart Diseases; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Norepinephrine; Physical Exertion; Prazosin; Quinazolines; Vascular Resistance | 1980 |
KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Dose-Response Relationship, Drug; Imidazoles; Isoenzymes; Kinetics; Molecular Structure; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Platelet Aggregation Inhibitors; Purines; Quinazolines; Rabbits; Sildenafil Citrate; Sulfones | 2001 |
Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine.
Topics: Acetylcholine; Administration, Oral; Alcohol Drinking; Animals; Apamin; Atropine; Blood Pressure; Bradykinin; Brazil; Charybdotoxin; Clonidine; Deoxycholic Acid; Drug Therapy, Combination; Endothelium, Vascular; Flavonoids; Glyburide; Guanylate Cyclase; Hypertension; Indomethacin; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; Oxadiazoles; Perfusion; Phenols; Polyphenols; Potassium Chloride; Pressure; Pyrilamine; Quinazolines; Quinoxalines; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Wine; Yohimbine | 2004 |
Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Tolerance; Femoral Artery; Femoral Vein; Hemodynamics; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilation | 2006 |
Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Migraine Disorders; Neurokinin-1 Receptor Antagonists; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Nitroglycerin; Piperazines; Piperidines; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Trigeminal Nerve; Vasodilator Agents; Wakefulness | 2014 |
Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response.
Topics: Analgesics; Animals; Hyperalgesia; Male; Migraine Disorders; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitroglycerin; Pain; Periaqueductal Gray; Quinazolines; Rats, Sprague-Dawley; Receptors, AMPA | 2020 |
No central action of CGRP antagonising drugs in the GTN mouse model of migraine.
Topics: Animals; Antibodies, Monoclonal; Calcitonin Gene-Related Peptide Receptor Antagonists; Disease Models, Animal; Injections, Intraventricular; Mice; Migraine Disorders; Nitroglycerin; Piperazines; Quinazolines; Vasodilator Agents | 2020 |
Acute Myocardial Infarction in an Adolescent Receiving Anagrelide for Essential Thrombocythemia with Underlying Persistent Coronary Endothelial Dysfunction.
Topics: Acetylcholine; Adolescent; Coronary Angiography; Coronary Vessels; Echocardiography; Endothelium, Vascular; Fibrinolytic Agents; Fibrosis; Heart Function Tests; Humans; Janus Kinase 2; Magnetic Resonance Imaging; Male; Nitroglycerin; Percutaneous Coronary Intervention; Quinazolines; Radionuclide Imaging; ST Elevation Myocardial Infarction; Thrombectomy; Thrombocythemia, Essential; Tomography, Optical Coherence; Tunica Intima; Vasodilator Agents | 2020 |